Latest filing published 02 Oct 2026 for AVIENT CORP. Read the official filing
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Filings by William R. Jellison span 4 companies, the busiest being Avient Corp, Anika Therapeutics, Inc. and Masimo Corp. The record holds 33 filings, for trades running from 31 December 2015 to 30 September 2026.
Every open-market trade on record is a purchase: 3 purchases worth €577k, and no sale. No amount is published for 1 filing, which the totals therefore leave out. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 30 share grants.
Across 3 purchases, this insider has always bought alone, with no colleague buying within 30 days.
The record was last updated on 2 October 2026 with a share grant in Avient Corp. The last purchase on record was published on 25 August 2025, which is 419 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 33 declarations